DeltaznuADeltapurE Brucella abortus 2308 mutant as a live vaccine candidate.

[1]  D. Lindsay,et al.  Wild boars as sources for infectious diseases in livestock and humans , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.

[2]  T. Ficht,et al.  The Brucella abortus S19 ΔvjbR Live Vaccine Candidate Is Safer than S19 and Confers Protection against Wild-Type Challenge in BALB/c Mice When Delivered in a Sustained-Release Vehicle , 2008, Infection and Immunity.

[3]  C. A. Fossati,et al.  Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  Xinghong Yang,et al.  Deletion of znuA Virulence Factor Attenuates Brucella abortus and Confers Protection against Wild-Type Challenge , 2006, Infection and Immunity.

[5]  S. Olsen,et al.  Efficacy of strain RB51 vaccine in heifers against experimental brucellosis. , 2006, Vaccine.

[6]  G. Riccardi,et al.  Protective Properties of Rifampin-Resistant Rough Mutants of Brucella melitensis , 2005, Infection and Immunity.

[7]  N. Commander,et al.  Brucellosis – new aspects of an old disease , 2005, Journal of applied microbiology.

[8]  Bruno Garin-Bastuji,et al.  From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. , 2005, Veterinary research.

[9]  M. Winkler,et al.  The Brucella abortus Cu,Zn Superoxide Dismutase Is Required for Optimal Resistance to Oxidative Killing by Murine Macrophages and Wild-Type Virulence in Experimentally Infected Mice , 2005, Infection and Immunity.

[10]  Zhang Qing,et al.  Completion of the Genome Sequence of Brucella abortus and Comparison to the Highly Similar Genomes of Brucella melitensis and Brucella suis , 2005, Journal of bacteriology.

[11]  M. Watarai,et al.  Zinc uptake system (znuA locus) of Brucella abortus is essential for intracellular survival and virulence in mice. , 2004, The Journal of veterinary medical science.

[12]  R. Roop,et al.  Intact Purine Biosynthesis Pathways Are Required for Wild-Type Virulence of Brucella abortus 2308 in the BALB/c Mouse Model , 2004, Infection and Immunity.

[13]  E. Moreno,et al.  Rough vaccines in animal brucellosis: structural and genetic basis and present status. , 2004, Veterinary research.

[14]  I. Moriyón,et al.  Characterization of Brucella abortus O-Polysaccharide and Core Lipopolysaccharide Mutants and Demonstration that a Complete Core Is Required for Rough Vaccines To Be Efficient against Brucella abortus and Brucella ovis in the Mouse Model , 2003, Infection and Immunity.

[15]  G. Splitter,et al.  Molecular Host-Pathogen Interaction in Brucellosis: Current Understanding and Future Approaches to Vaccine Development for Mice and Humans , 2003, Clinical Microbiology Reviews.

[16]  Nammalwar Sriranganathan,et al.  Brucellosis vaccines: past, present and future. , 2002, Veterinary microbiology.

[17]  R. Verdun,et al.  Gene Discovery through Genomic Sequencing of Brucella abortus , 2001, Infection and Immunity.

[18]  J. Blasco,et al.  In vitro markers and biological activity in mice of seed lot strains and commercial Brucella melitensis Rev 1 and Brucella abortus B19 vaccines. , 2000, Biologicals : journal of the International Association of Biological Standardization.

[19]  T. Hadfield,et al.  Protection of Mice against Brucellosis by Vaccination with Brucella melitensisWR201(16MΔpurEK) , 1999, Infection and Immunity.

[20]  M. Palmer,et al.  Responses of cattle to two dosages of Brucella abortus strain RB51: serology, clearance and efficacy. , 1999, Research in veterinary science.

[21]  L. Colby,et al.  Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51. , 1998, American journal of veterinary research.

[22]  G. Schurig,et al.  Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence. , 1998, American journal of veterinary research.

[23]  K. Hantke,et al.  The ZnuABC high‐affinity zinc uptake system and its regulator Zur in Escherichia coli , 1998, Molecular microbiology.

[24]  J. Blasco,et al.  A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats. , 1997, Preventive veterinary medicine.

[25]  M. J. Corbel,et al.  Brucellosis: an overview. , 1997, Emerging infectious diseases.

[26]  M. Palmer,et al.  Effects of age at vaccination on efficacy of Brucella abortus strain RB51 to protect cattle against brucellosis. , 1996, American journal of veterinary research.

[27]  T. Hadfield,et al.  Bacterial persistence and immunity in goats vaccinated with a purE deletion mutant or the parental 16M strain of Brucella melitensis , 1996, Infection and immunity.

[28]  T. Hadfield,et al.  Deletion of purE attenuates Brucella melitensis infection in mice , 1996, Infection and immunity.

[29]  J. Liautard,et al.  Interactions between professional phagocytes and Brucella spp. , 1996, Microbiologia.

[30]  S. Olsen,et al.  Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51 , 1995, Infection and immunity.

[31]  M. Palmer,et al.  Immune and pathologic responses in mice infected with Brucella abortus 19, RB51, or 2308 , 1994, Infection and immunity.

[32]  N. Cheville,et al.  Brucella abortus-associated Meningitis in Aborted Bovine Fetuses , 1991, Veterinary pathology.

[33]  G. Schurig,et al.  Biological properties of RB51; a stable rough strain of Brucella abortus. , 1991, Veterinary microbiology.

[34]  P. Nicoletti.  Vaccination against Brucella. , 1990, Advances in biotechnological processes.

[35]  B. L. Deyoe,et al.  Intracellular Localization of Brucella abortus in Bovine Placenta , 1989, Veterinary pathology.

[36]  B. Harmon,et al.  Survival of rough and smooth strains of Brucella abortus in bovine mammary gland macrophages. , 1988, American journal of veterinary research.

[37]  A. Ardalan,et al.  Effect of living Rev. 1 vaccine in producing long-term immunity against Brucella melitensis infection in sheep in Iran. , 1967, Journal of comparative pathology.